Vaxcyte Inc.

NASDAQ: PCVX
Share price (8/14/25): $31.43
Market cap (8/14/25): $4.080 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Janus Henderson Group plc

News Filter

Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-In-Class Pneumococcal Conjugate Vaccine

Shareholder Vote Results

Reports First Quarter 2025 Financial Results and Provides Business Update

Change in Directors, Officers or Compensation

Announces Positive Topline Results From VAX-24 Infant Phase 2 Dose-Finding Study

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Scanned paper annual report submission